China Shineway Pharmaceutical GroupCSWYF 92 Dividend Payout Ratio is 0.23 as of Dec. 2025, which is 41% below its 10-year median of 0.39. GuruFocus rates CSWYF with a GF Score™ of 92/100 and a GF Value™ of $0.88. The stock has 2 warning signs investors should review. Among 443 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 53.5% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. China Shineway Pharmaceutical Group's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.23.
The historical rank and industry rank for China Shineway Pharmaceutical Group's Dividend Payout Ratio or its related term are showing as below:
CSWYF'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.39 Max: 0.8
Current: 0.36
During the past 13 years, the highest Dividend Payout Ratio of China Shineway Pharmaceutical Group was 0.80. The lowest was 0.33. And the median was 0.39.
CSWYF's Dividend Payout Ratio is ranked better than 53.5% of 443
companies
in the Drug Manufacturers industry
Industry Median: 0.37
vs CSWYF: 0.36
During the past 13 years, the highest Trailing Annual Dividend Yield of China Shineway Pharmaceutical Group was 15.10%. The lowest was 0.00%. And the median was 4.84%.
During the past 12 months, China Shineway Pharmaceutical Group's average Dividends Per Share Growth Rate was -8.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 12.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 8.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 8.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of China Shineway Pharmaceutical Group was 27.50% per year. The lowest was -7.80% per year. And the median was 5.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
China Shineway Pharmaceutical Group (OTCPK:CSWYF) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
China Shineway Pharmaceutical Group Dividend Payout Ratio Related Terms
China Shineway Pharmaceutical Group Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Dividend Payout Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's Dividend Payout Ratio falls into.
China Shineway Pharmaceutical Group Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group (CSWYF) has a Dividend Payout Ratio of 0.23 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 41% below median its historical median of 0.39. Over the past decade, China Shineway Pharmaceutical Group's Dividend Payout Ratio has ranged from 0.33 to 0.80. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #206 out of 443 companies in the Drug Manufacturers industry, placing it in the top 46.5%.
Is China Shineway Pharmaceutical Group's Dividend Payout Ratio too high?
China Shineway Pharmaceutical Group's current Dividend Payout Ratio of 0.23 is 41% below median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 0.80. The Drug Manufacturers industry median Dividend Payout Ratio is 0.37. China Shineway Pharmaceutical Group's value of 0.23 is 37.8% below this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #206 out of 443 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #206 out of 443 companies for Dividend Payout Ratio. This puts China Shineway Pharmaceutical Group in the upper half of its industry. The industry median Dividend Payout Ratio is 0.37. China Shineway Pharmaceutical Group's value of 0.23 is 37.8% below this benchmark. Historically, China Shineway Pharmaceutical Group's own Dividend Payout Ratio has ranged from 0.33 to 0.80 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.37, China Shineway Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.37, based on 443 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Dividend Payout Ratio of 0.23 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Dividend Payout Ratio is 0.23, which is 41% below median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current Dividend Payout Ratio of 0.23. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current Dividend Payout Ratio is 0.23, which is 41% below median its 10-year median of 0.39 and 37.8% below the Drug Manufacturers industry median of 0.37. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current Dividend Payout Ratio is 0.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.
Key valuation signals for CSWYF:
Dividend Payout Ratio: 0.23 (41% below median its 10-year median of 0.39)
GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
Industry Position: 37.8% below the Drug Manufacturers median (#206 of 443)
No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYF
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYF has been successfully added to your 
